Fig. 6 | Scientific Reports

Fig. 6

From: ALKBH5 acts a tumor-suppressive biomarker and is associated with immunotherapy response in hepatocellular carcinoma

Fig. 6

Patients in the two subtypes exhibit different immune infiltration and TIME. (A) The immune cell infiltration in the two HCC subtypes. (B) The TME score in the two HCC subtypes. (C) The relationship between HCC subtypes and immune subtypes. (D) Correlation analysis of the key MRGs and immune cell infiltration. (*P < 0.05, **P < 0.01, ***P < 0.001).

Back to article page